Clinical Trials Browser

Phase 2 × OTHER × Neoplasms, Second Primary × Clear all

NCT04634071 2026-02-02

TTOP

Phase 2 Completed

Smoking Cessation, Neoplasms, Second Primary, Behavior, Addictive

NCT05217069 2025-04-16

FOLFIRI + Cetuximab + Avelumab RAS Wild-type CRC

Phase 2 Completed

Neoplasms, Second Primary

NCT05855811 2024-07-15

PREDOSTAR

Phase 2 Recruiting

Neoplasms, Recurrence, Neoplasms, Second Primary

NCT02530515 2019-10-29

Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia

Phase 2 Completed

8 enrolled 6 charts

Classical hematologyLymphoidOther hematologic neoplasm

Lymphadenopathy, Anemia, Communicable Diseases, Fever, Lymphocytosis, Thrombocytopenia, Weight Loss, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Neoplasms, Second Primary

NCT04034173 2019-07-26

Optimal Anti-EGFR Treatment of mCRC Patients With Low-Frequency RAS Mutation

Phase 2 Not yet recruiting

Gastrointestinal

Colorectal Neoplasms, Neoplasms, Second Primary

NCT00400426 2013-06-19

DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer

Phase 2 Completed

Head and Neck Neoplasms, Recurrence, Neoplasms, Second Primary